Advances in the Diagnosis and Management of Atrial Fibrillation and Heart Failure
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 1366
Special Issue Editor
Special Issue Information
Dear Colleagues,
The interaction between atrial fibrillation (AF) and heart failure (HF) is a complex and multifactorial problem that requires further investigation. The coexistence of AF and HF can lead to a vicious cycle where each condition exacerbates the other through mechanisms such as structural cardiac remodeling and activation of neurohormonal systems. The clinical course of AF and HF varies depending on the cause and type of CHF and AF.
Age and HF severity are significant risk factors for the development of AF in patients with HF, and the clinical course seems more favorable when AF causes HF than with other causes of HF. However, the development of AF in patients with chronic HF is associated with a worse prognosis, including stroke and increased mortality.
New cardiac-specific biomarkers, cardiac imaging and remote monitoring can potentially improve the diagnosis and understanding of AF and HF disease progression, but more research is needed to determine their influence on both diseases.
With the advancements in digital technology, there are many opportunities for early diagnosis of AF and CHF. The Special Issue will explore the latest research on this topic and provide insights into the prevention, diagnosis, and treatment of both conditions. This issue aims to add value to the scientific community and improve the lives of patients suffering from AF and HF by providing a comprehensive understanding of the interaction between these two conditions and the optimal management of patients with both AF and HF.
Dr. Denis Losik
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- heart failure
- biomarkers
- cardiac imaging
- remote monitoring
